AR003997A1 - 2-[2-[(2-hidroxietil)amino]etil]-5-[[2-(metilamino)-etil]amino]indazol[4,3- gh]isoquinolin-6(2h)-ona, procesos para la preparacion del mismo y delintermediario y composiciones farmaceuticas que contienen el compuesto principal. - Google Patents

2-[2-[(2-hidroxietil)amino]etil]-5-[[2-(metilamino)-etil]amino]indazol[4,3- gh]isoquinolin-6(2h)-ona, procesos para la preparacion del mismo y delintermediario y composiciones farmaceuticas que contienen el compuesto principal.

Info

Publication number
AR003997A1
AR003997A1 ARP960104329A AR10432996A AR003997A1 AR 003997 A1 AR003997 A1 AR 003997A1 AR P960104329 A ARP960104329 A AR P960104329A AR 10432996 A AR10432996 A AR 10432996A AR 003997 A1 AR003997 A1 AR 003997A1
Authority
AR
Argentina
Prior art keywords
ethyl
amino
isoquinolin
hydroxyethyl
indazol
Prior art date
Application number
ARP960104329A
Other languages
English (en)
Original Assignee
Novuspharma Spa
Univ Vermont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novuspharma Spa, Univ Vermont filed Critical Novuspharma Spa
Publication of AR003997A1 publication Critical patent/AR003997A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se relaciona con 2-[2-[(2-hidroxietil)amino]etil]-5- [[2-(metilamino)etil]amino]-indazol[4,3-gh]isoquinolin-6(2H)-ona y sus salesde adición ácida aceptables para uso farmacéutico de fórmula (I). Se ha demostrado que este compuesto posee una elevada actividad antitumoral.
ARP960104329A 1995-09-13 1996-09-12 2-[2-[(2-hidroxietil)amino]etil]-5-[[2-(metilamino)-etil]amino]indazol[4,3- gh]isoquinolin-6(2h)-ona, procesos para la preparacion del mismo y delintermediario y composiciones farmaceuticas que contienen el compuesto principal. AR003997A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI001904A IT1277576B1 (it) 1995-09-13 1995-09-13 2-2-(2-idrossietil) ammino etil -5- 2-metilammino etil ammino indazolo 4,3-gh isochinolin-6 (2h)-one come agente antitumorale

Publications (1)

Publication Number Publication Date
AR003997A1 true AR003997A1 (es) 1998-09-30

Family

ID=11372237

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960104329A AR003997A1 (es) 1995-09-13 1996-09-12 2-[2-[(2-hidroxietil)amino]etil]-5-[[2-(metilamino)-etil]amino]indazol[4,3- gh]isoquinolin-6(2h)-ona, procesos para la preparacion del mismo y delintermediario y composiciones farmaceuticas que contienen el compuesto principal.

Country Status (15)

Country Link
US (1) US6034092A (es)
EP (1) EP0876369A1 (es)
JP (1) JPH11512409A (es)
KR (1) KR19990044614A (es)
CN (1) CN1196055A (es)
AR (1) AR003997A1 (es)
AU (1) AU6988296A (es)
BR (1) BR9610601A (es)
CZ (1) CZ286654B6 (es)
HU (1) HUP9901348A3 (es)
IL (1) IL123619A0 (es)
IT (1) IT1277576B1 (es)
NO (1) NO981093L (es)
WO (1) WO1997010245A1 (es)
ZA (1) ZA967706B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6747039B2 (en) * 2002-03-12 2004-06-08 Albany Molecular Research, Inc. Aza-benzothiopyranoindazoles with antitumor activity
KR20070110046A (ko) * 2005-01-28 2007-11-15 크산투스 파마슈티컬스, 인코포레이티드 염증 및 탈수초성 질환을 치료하기 위한 화합물
CN103787970A (zh) * 2014-01-14 2014-05-14 北京万全德众医药生物技术有限公司 一锅煮法制备6，9-二氟苯并异喹啉-5，10-二酮的工艺

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69211A (en) * 1982-07-23 1987-01-30 Warner Lambert Co Substituted anthra(1,9-cd)pyrazol-6(2h)-ones,their preparation and pharmaceutical compositions containing them
WO1994006795A1 (en) * 1992-09-08 1994-03-31 The University Of Vermont 2-aminoalkyl-5-aminoalkylamino substituted isoquinoindazole-6-(2h)-ones with antitumour activity
US5519029A (en) * 1992-09-08 1996-05-21 Boehringer Mannheim Italia, S.P.A. 2-aminoalkyl-5-aminoalkylamino substituted-isoquinoindazole-6(2H)-ones
US5596097A (en) * 1994-03-08 1997-01-21 The University Of Vermont Hetero-annulated indazoles

Also Published As

Publication number Publication date
ITMI951904A1 (it) 1997-03-13
BR9610601A (pt) 1999-12-21
AU6988296A (en) 1997-04-01
WO1997010245A1 (en) 1997-03-20
ZA967706B (en) 1997-03-25
CZ75098A3 (cs) 1998-07-15
IT1277576B1 (it) 1997-11-11
EP0876369A1 (en) 1998-11-11
CN1196055A (zh) 1998-10-14
HUP9901348A3 (en) 2000-03-28
NO981093D0 (no) 1998-03-12
NO981093L (no) 1998-03-12
US6034092A (en) 2000-03-07
HUP9901348A2 (hu) 1999-08-30
CZ286654B6 (cs) 2000-05-17
JPH11512409A (ja) 1999-10-26
KR19990044614A (ko) 1999-06-25
IL123619A0 (en) 1998-10-30
ITMI951904A0 (it) 1995-09-13

Similar Documents

Publication Publication Date Title
CA2086654A1 (en) Novel pharmaceutically active 1,2,4-triaminobenzene derivatives, processes for their preparation and pharmaceutical compositions containing them
EP1068219A4 (en) ACYLATED BETULIN AND DIHYDROBETULIN DERIVATIVES, THEIR PREPARATION AND USE
LU91206I2 (fr) Ceftiofur sous forme d'acide libre cristallin et ses dérivés pharmaceutiquement acceptables (naxcel)
AU4264396A (en) Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
ATE185792T1 (de) Stilbenderivate und diese enthaltende pharmazeutische zusammensetzungen
HUP0302980A2 (hu) Lipofil és ionizálható molekularészeket tartalmazó protein junkinázgátló hatású szulfonamid-származékok és ezeket tartalmazó gyógyszerkészítmények
ATE202337T1 (de) Cyclopropylalkansäurederivate
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
MX9701538A (es) Sales de un derivado del indol contra la migraña.
MXPA02005536A (es) Acidos aminopropilfosfinicos novedosos.
FI933424A0 (fi) Peptidyl-4-amino-2,2-difluor-3-oxo-1,6-hexandisyraderivat som antiinflammatoriska medel
DK1109560T3 (da) Som AICARFT-inhibitorer anvendelige forbindelser
EP1019047A4 (en) ANTITHROMBOTIC AGENTS
FI943931A (fi) Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina
IL113365A0 (en) 5-heterocyclo-1,5-benzodiazepine derivatives, their preparation and use and pharmaceutical compositions containing them
AR003997A1 (es) 2-[2-[(2-hidroxietil)amino]etil]-5-[[2-(metilamino)-etil]amino]indazol[4,3- gh]isoquinolin-6(2h)-ona, procesos para la preparacion del mismo y delintermediario y composiciones farmaceuticas que contienen el compuesto principal.
ES2135695T3 (es) Derivados de aminoacidos y su uso como inhibidores de la fosfolipasa a2.
NO983444L (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
AU558261B2 (en) Dialkylaminoalkyoxybenzylalcohol derivatives
NO980058L (no) Opthalmiske preparater
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
NO950177L (no) Farmakologisk aktive erivater
NO973341L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakse
DE69824410D1 (en) Antithrombosemittel